Is Nortech Systems Incorporated (NSYS) overvalued? · P/E 44, rev $14.4M
Nortech Systems Incorporated (NSYS) is a medical devices company listed on US.
This page asks whether Nortech Systems Incorporated (NSYS) looks expensive on cached numbers — not a short thesis.
Latest reported NSYS revenue for 2024-12-31 was $14.4M. Net income was -$1.3M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. NSYS currently screens at market cap $46.2M and trailing P/E 43.6.
NSYS currently screens at market cap $46.2M and trailing P/E 43.6. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NSYS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NSYS stock page for the full model, not this heading.
Not investment advice.